IPD Products

Patented Air Sterilizer to Eliminate Covid-19

Join CrowdabilityIQ to access our premium risk and value analysis for this deal.

Company Information




Cleaning Systems


Midlothian, TX

IPD Products has designed an air sterilization product — the Ionic Plague Destroyer.

This product is engineered to combat airborne pathogens, such as SARS-CoV-2, the virus responsible for Covid-19. The device removes pathogens from the air and creates a healthy and safe indoor environment.

IPD Products was founded just six months ago. But it has already secured an agreement to control a patent that covers methods for air disinfection and sterilization.

The company’s President Howard Nelson has extensive experience commercializing technologies for Bristol Myers Squibb, Honeywell, and Pfizer.

Meanwhile, Chief Science Officer Alexander Gutsol is co-founder of the Drexel Plasma Research Institute, and has invented dozens of patented products. He also spent nearly a decade as a technical lead and principal scientist at Chevron.

IPD Products has developed the Ionic Plague Destroyer as its flagship product. The company is raising this first round of capital to ramp up manufacturing and production in anticipation for a launch in Q4 2020.

As of mid-August, there are more than 21.8 million reported cases of Covid-19 worldwide — 5.4 million in the U.S. alone.

Many experts believe the virus is more easily spread indoors. However, some airborne disease transmission experts believe that air purifiers could potentially help in reducing transmission.

IPD Products has created an air purifier that can rapidly sterilize the air in places where face-to-face communication occurs.

The company has developed two models, the IPD 100 and IPD 600. The IPD 100 is suitable for in-home and personal space use, while the IPD 600 is intended to purify larger areas like a conference room or office.

Both products are portable, and don’t require the user to replace any filters. Features include USB port access, omnidirectional filtration, quiet fan-powered operation, and the ability to plug into a standard outlet.

What makes these filters unique is the use of PlasmaFence technology. Essentially, this technology eliminates pathogens, rather than simply filtering them.

PlasmaFence employs six plasma modalities in synergy to destroy airborne pathogens. These are electric field, ions, radicals, ozone, ultraviolet light, and localized temperature increase.

This technology is supported by patented technology that IPD Products’ Chief Science Officer co-invented. This patent covers a method for decontaminating bioaerosols with high concentrations of bacterial, viral, and other airborne microorganisms.

IPD Products has licensed this patent from Drexel University. The licensing agreement is subject to the company meeting certain milestones, including raising capital, commercial product release, and sales targets.

Once ready for market, IPD Products aims to sell its sterilizers to businesses and consumers.

For businesses, the company plans to use sales representatives and a direct online sales channel. For consumer sales, it will use the same online sales channel, and sell through partners such as Lowe’s and Home Depot.

IPD Products plans to sell its sterilizers for $1,000 at retail. Per the licensing agreement, the company will pay Drexel a quarterly royalty equal to 2.5% of its net sales.

In 2021, IPD Products aims to expand its product line and include its sterilization technology in HVAC Systems and Personal Protective Equipment, such as face masks.

Team Background

Howard Nelson - President

Howard has spent his career commercializing new products and technologies in the healthcare, software, and chemical processes industries.

He began as a business analyst with Pfizer, a pharmaceutical company. From there, he was Director of Licensing and Business Development for Bristol Myers Squibb, another pharmaceutical company.

Howard then spent 10 years as President of Fiber-Tec, a fiberglass supply company. After that, he was Chief Strategy Officer and President of Origin, an agricultural startup.

He spent the past 13 years as an adjunct professor at The College of New Jersey, teaching in the Economics Department. He also served as an executive with LDS Technology, a consulting business.

He earned a Bachelor’s degree in Economics from Princeton and an MBA from Tulane.

Alexander Gutsol - Chief Science Officer

Alexander is the inventor of the patent behind IPD Products’ sterilizer.

He began his career as a senior research scientist at the University of Illinois at Chicago. From there, he moved to Drexel University, where he became a research professor, and co-founded the Drexel Plasma Research Institute. While there, he was awarded several patents for his inventions.

He then began a nine-year career with Chevron, an oil and energy company. He served as a principal scientist and a technical team leader. More recently, he was Chief Scientist with LDS Technology, the consulting business run by Howard Nelson.

Alexander holds a Bachelor’s degree and Master’s degree in Engineering Physics from Moscow Institute of Physics and Technology, and a Ph.D. from the same university.

Eric Anthony - Counsel

Eric has owned his own legal practice for 23 years. He specializes in business formation.

In addition to this experience, he previously co-founded LDS Technology, the consulting business run by Howard Nelson.

Eric earned a Bachelor’s degree in Accounting from Southwest Texas State University and a JD from St. Mary’s University.

Sharon Naismith - Chief Financial Officer

Sharon has extensive experience as a public accountant.

Prior to IPD Products, she was a senior tax accountant for Carr, Riggs & Ingram, an accounting practice. Before that, she held the same position for Cazalas & Hunter, another accounting firm.

Her accounting experience before that was while working as an audit manager with King Griffin & Adamson, an accounting company. She began her career as an audit associate with Coopers & Lybrand, an accounting firm that later became PricewaterhouseCoopers.

Sharon holds a Bachelor’s degree in Accounting from Texas A&M University.

$1.07 million
$25K (2%)
Current Valuation
$5 million Cap / 20% Discount
Min. Investment
Deal Type
Title III
(For all investors)
Offering Type
Convertible Debt
Learn more on MicroVentures